Susan Moran
Independent DirectorDr. Susan Moran, M.D., M.S.C.E., serves as Advisor of Alterome Therapeutics, Inc. She serves as Independent Director of Crescent Biopharma Inc. since November 2024. Dr. Moran serves as Independent Director of Tyra Biosciences, Inc. since May 07, 2024. She served as the Chief Medical Officer of RayzeBio, Inc. since July 2021. She has successfully led programs from IND clearance to full regulatory approval. Prior to RayzeBio, she led the clinical efforts that led to FDA approval of Truseltiq for cholangiocarcinoma. She has been Independent Director at BioAtla, Inc. since December 2020. She has industry and academic experience, successfully leading clinical trials from Phase 1 to Phase 3, as well as NDA and MAA submissions for various investigational products including the successful approval of Nerlynx. Most recently, Dr. Moran serves as Chief Medical Officer of QED Therapeutics, a BridgeBio affiliate, since March 2018. Prior to that, Dr. Moran was at Puma Biotechnology, Inc. from 2014 to February 2018. She was Senior Medical Director until December 2016, when her role expanded to Vice President and Head of Clinical Development. She held senior positions at Takeda (previously Millennium) and Sanofi (former Genzyme). Dr. Moran has played roles in the development, registration and post marketing support of products for breast, prostate, thyroid, bile duct and urothelial cancer as well as multiple sclerosis and other disorders. She is a board certified internist and has served on the faculty of the University of Pennsylvania School of Medicine and Harvard Medical School. She received her B.A. with chemistry from the University of Virginia, M.D. from Duke University and M.S. in Clinical Epidemiology from the University of Pennsylvania School of Medicine.
Positions
- Company NameTyra Biosciences, Inc.Stock CodeTYRAPositionIndependent DirectorColleagues
- THTodd HarrisCo-Founder, CEO, President & Director
- BABhavesh AsharChief Operating Officer
- DWDouglas WarnerChief Medical Officer
- DBDaniel BensenCo-Founder & Chief Discovery Officer
- AFAlan FuhrmanChief Financial Officer
- RJRobert J. MoreIndependent Director
- RVRehan VerjeeIndependent Director
- JSJake SimsonIndependent Director
